Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC6A4 | P31645 | 7/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 6/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | OPRD1 | P41143 | 6/20 | 0.34 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.32 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.32 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.31 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.31 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.31 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.31 |
| ▸ | CACNA1F | O60840 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | CACNA1D | Q01668 | 1/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | CACNA1S | Q13698 | 1/20 | 0.31 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6556075 | 0.97 | SLC6A4 (0.36) | SLC6A4SLC6A2MEN1KMT2AOPRD1 | |
| SCHEMBL2673825 | 0.91 | SLC6A2 (0.33) | SLC6A4SLC6A2MEN1KMT2AOPRD1 | |
| SCHEMBL5584107 | 0.89 | CXCR4 (0.42) | SLC6A4SLC6A2MEN1KMT2AOPRD1 | |
| SCHEMBL28226868 | 0.89 | SIGMAR1 (0.36) | SLC6A4SLC6A2MEN1KMT2AOPRD1 | |
| SCHEMBL2958702 | 0.85 | KMT2A (0.35) | SLC6A4SLC6A2MEN1KMT2AOPRD1 | |
| SCHEMBL6578962 | 0.81 | SIGMAR1 (0.36) | SLC6A4SLC6A2MEN1KMT2AOPRD1 | |
| SCHEMBL11724424 | 0.78 | SIGMAR1 (0.37) | SLC6A4SLC6A2MEN1KMT2AOPRD1 | |
| SCHEMBL30611837 | 0.78 | KDM4E (0.36) | SLC6A4SLC6A2MEN1KMT2AOPRD1 | |
| SCHEMBL9695357 | 0.78 | — | — | |
| SCHEMBL510134 | 0.77 | SLC6A2 (0.39) | SLC6A4SLC6A2MEN1KMT2AOPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080293917-A1 | Peptide Purification By Means Of Metal Ion Affinity Chromatography | NOVO NORDISK A/S (DK) | 2008-11-27 | — | — | US | disclosed |
| US-20060287432-A1 | Peptide purification by means of metal ion affinity chromatography | NOVO NORDISK A/S (DK) | 2006-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080293917-A1 | Peptide Purification By Means Of Metal Ion Affinity Chromatography | NGLY1, VIP, NPPA | SLC6A4 1968/4885SLC6A2 2375/4885MEN1 1589/4885 |
| US-20060287432-A1 | Peptide purification by means of metal ion affinity chromatography | NGLY1, VIP, NPPA | SLC6A4 1968/4885SLC6A2 2375/4885MEN1 1589/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.